Multicenter Automatic Defibrillator Implantation Trial II - MADIT-II


The purpose of the study was to evaluate the prophylactic benefit of implantable cardioverter-defibrillator (ICD) placement in patients with coronary artery disease and a left ventricular ejection fraction (LVEF) of ≥30%, who have had at least one myocardial infarction (MI), but require no further risk stratification.